Remediation of Spatial Neglect Trial
RESPONSE
RESPONSE: Remediation of Spatial Neglect Trial
1 other identifier
interventional
96
1 country
1
Brief Summary
Problems with attention are a common and debilitating consequence of brain injury. Studies show that poor attention is the number one predictor of poor cognitive functioning one year post-injury. This is due to the fact that attention is a necessary component of more complex cognitive functions such as learning \& memory, multi-tasking and problem solving. In many cases, individuals may exhibit problems with spatial attention known as 'hemi-spatial neglect syndrome' or simply 'neglect'. Many studies now show that the processing machinery of the brain is plastic and remodeled throughout life by learning and experience, enabling the strengthening of cognitive skills or abilities. Research has shown that brief, daily computerized cognitive training that is sufficiently challenging, goal-directed and adaptive enables intact brain structures to restore balance in attention and compensate for disruptions in cognitive functioning. The study aims to understand how our computer program can affect cognition and attention in those with acquired brain injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable stroke
Started Jul 2013
Longer than P75 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2013
CompletedFirst Submitted
Initial submission to the registry
October 16, 2013
CompletedFirst Posted
Study publicly available on registry
October 18, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2017
CompletedJuly 7, 2020
July 1, 2020
3.7 years
October 16, 2013
July 2, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Performance on Posner Cueing Task
Between-group magnitude of change in reaction time (RT) for RT detecting targets appearing on the left side of the display minus the RT for detecting targets appearing on the right side of the display as measured by Posner Cueing Task. Positive reaction time difference scores indicate a rightward bias; whereas, negative reaction time difference scores indicate a leftward bias in spatial attention.
At 3 months
Secondary Outcomes (6)
Change in Spatial Cognition (Multiple scores are aggregated to arrive at a single composite score)
At 3 months and at 6 months
Change in Cognitive Performance (Multiple scores are aggregated to arrive at a single composite score)
At 3 months and at 6 months
Change in Functional Ability (Multiple scores are aggregated to arrive at a single composite score)
At 3 months and at 6 months
Change in Quality of Life (Multiple scores are aggregated to arrive at a single composite score)
At 3 months and at 6 months
Change in Quality of Sleep: Pittsburgh Sleep Quality Index (Multiple scores are aggregated to arrive at a single composite score)
At 3 months and at 6 months
- +1 more secondary outcomes
Study Arms (2)
Experimental Treatment
EXPERIMENTALComputerized Plasticity-based Adaptive Cognitive Training requiring a total maximum of 39 treatment sessions, 4-5 times weekly, \~30 mins each session.
Active Comparator
ACTIVE COMPARATORCommercially available computerized training requiring a total maximum of 39 treatment sessions, 4-5 times weekly, \~30 mins each session.
Interventions
Computerized Plasticity-based Adaptive Cognitive Training requiring a total maximum of 39 treatment sessions, 4-5 times weekly, \~30 mins each session.
Commercially available computerized training requiring a total maximum of 39 treatment sessions, 4-5 times weekly, \~30 mins each session.
Eligibility Criteria
You may qualify if:
- years of age or older
- Diagnosis of an acquired brain injury (which may be in the form of a stroke or brain tumor removal) and
- Evidence of deficit on at least 2 out of 4 assessment measures of Spatial Neglect: Mesulam Cancelation task (ages 50 and younger \> 0 omissions; 51-80 \> 4 omissions), Dual task (\>19% difference in accuracy for right - left target trials), Tone Counting task (\< 94% total accuracy), or Landmark task (deviation from objective center as determined by the 95% confidence interval, with neglect indicated with 'Y' and no neglect with 'N' following completion of task).
- Must be at least 3 months out from their most recent acquired brain injury, stroke, or brain tumor removal
- Fluent English speakers
- Adequate sensorimotor capacity to participate in the trial, including visual capacity adequate to read from a computer screen at a normal viewing distance, auditory capacity adequate to understand normal speech, and motor capacity adequate to control a computer mouse
You may not qualify if:
- A conjunction of prior acquired brain injury and score \>8 on Blessed Scale - Short Form
- Diagnosis of severe depression (a score of \>29 on Beck Depression Inventory (BDI-II)
- Diagnosis of chronic psychiatric disorders with associated cognitive impairments, eg. Schizophrenia
- Diagnosis of illness, condition or treatment with known cognitive consequences, eg. chemotherapy
- Active Suicidal Ideation with Specific Plan and Intent or any suicide-related behaviors within 2 months of consent
- A current or significant past history of substance abuse
- Difficulty completing assessments and/or comprehending requirements of trial
- Enrollment in a concurrent clinical trial involving an investigational pharmaceutical, nutraceutical, medical device or behavioral treatment that could affect the outcome of this study
- Complete primary visual field deficit, score of 3 on NIH Stroke Scale - Visual Field Subscale
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Posit Science Corporationlead
- Washington University School of Medicinecollaborator
- VA Boston Healthcare Systemcollaborator
- Spaulding Rehabilitation Hospitalcollaborator
Study Sites (1)
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Related Publications (6)
Friedrich FJ, Egly R, Rafal RD, Beck D. Spatial attention deficits in humans: a comparison of superior parietal and temporal-parietal junction lesions. Neuropsychology. 1998 Apr;12(2):193-207. doi: 10.1037//0894-4105.12.2.193.
PMID: 9556766BACKGROUNDHusain M, Kennard C. Visual neglect associated with frontal lobe infarction. J Neurol. 1996 Sep;243(9):652-7. doi: 10.1007/BF00878662.
PMID: 8892067BACKGROUNDHeilman KM, Bowers D, Valenstein E, Watson RT. Disorders of visual attention. Baillieres Clin Neurol. 1993 Aug;2(2):389-413. No abstract available.
PMID: 8137006BACKGROUNDMort DJ, Malhotra P, Mannan SK, Rorden C, Pambakian A, Kennard C, Husain M. The anatomy of visual neglect. Brain. 2003 Sep;126(Pt 9):1986-97. doi: 10.1093/brain/awg200. Epub 2003 Jun 23.
PMID: 12821519BACKGROUNDPosner MI, Walker JA, Friedrich FJ, Rafal RD. Effects of parietal injury on covert orienting of attention. J Neurosci. 1984 Jul;4(7):1863-74. doi: 10.1523/JNEUROSCI.04-07-01863.1984.
PMID: 6737043BACKGROUNDVleet TV, DeGutis J, Dabit S, Chiu C. Randomized control trial of computer-based rehabilitation of spatial neglect syndrome: the RESPONSE trial protocol. BMC Neurol. 2014 Feb 7;14:25. doi: 10.1186/1471-2377-14-25.
PMID: 24502769DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Van Vleet, PhD
Posit Science Corporation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 16, 2013
First Posted
October 18, 2013
Study Start
July 1, 2013
Primary Completion
March 1, 2017
Study Completion
March 1, 2017
Last Updated
July 7, 2020
Record last verified: 2020-07